4-Bromo-2-(trifluoromethoxy)iodobenzene, 97.0%, 500g

n-[(2,4-dimethoxyphenyl)methyl]-3-iodo-1h-pyrazolo[4,3-c]pyridin-4-amine, 98%, 25g

Ethyl 4-amino-5-(4-chloro-3-nitrobenzoyl)-2-((2-(trifluoromethyl)phenyl)amino)thiophene-3-carboxylate, 95%, 25mg

3-Fluoro-2-methylbenzenesulfonamide, 97.0%, 5g

Ethyl 2-chloro-5-methylisonicotinate, 95.0%, 1g

(S)-1-(2-Methoxypyridin-4-yl)ethanamine hydrochloride, 96.0%, 250mg

2-(4-Chloro-phenylamino)-thiazole-4-carboxylic acid, 95.0%, 100mg

(R)-1-(4-Fluoro-2-methylphenyl)ethanamine hydrochloride, 98%, 250mg

N-[2-(1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]propanamide, 98%, 5g

1,2-Dibromo-4-tert-butylbenzene, 97.0%, 25g

Venlafaxine Hydrochloride>98.0%(HPLC)(T)1g

Kit d'essai Spectra/Por® 1-3 Spectra/Por® 1 – MWCO 6000–8000, 50 mm, 1 pièce(s)

2-ETHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIAZOLE, 95.0%, 1g